FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 1 filers reported holding FULCRUM THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,297 | -35.9% | 5,247 | -52.4% | 0.00% | 0.0% |
| Q2 2023 | $36,366 | +213817.6% | 11,020 | +86.1% | 0.00% | 0.0% |
| Q1 2023 | $17 | +30.8% | 5,920 | +224.6% | 0.00% | 0.0% |
| Q4 2022 | $13 | -99.9% | 1,824 | -13.7% | 0.00% | – |
| Q3 2022 | $17,000 | -39.3% | 2,113 | -64.2% | 0.00% | -100.0% |
| Q2 2022 | $28,000 | +75.0% | 5,903 | +789.0% | 0.00% | – |
| Q1 2022 | $16,000 | -75.4% | 664 | -81.7% | 0.00% | -100.0% |
| Q4 2021 | $65,000 | +333.3% | 3,627 | +579.2% | 0.00% | – |
| Q3 2021 | $15,000 | -11.8% | 534 | -67.7% | 0.00% | – |
| Q2 2021 | $17,000 | +41.7% | 1,653 | +62.1% | 0.00% | – |
| Q1 2021 | $12,000 | -80.3% | 1,020 | -80.4% | 0.00% | -100.0% |
| Q4 2020 | $61,000 | -43.0% | 5,199 | -61.6% | 0.00% | +100.0% |
| Q3 2020 | $107,000 | +137.8% | 13,555 | +448.6% | 0.00% | -50.0% |
| Q2 2020 | $45,000 | +650.0% | 2,471 | +165.4% | 0.00% | – |
| Q3 2019 | $6,000 | – | 931 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 2,343,154 | $10,403,604 | 3.92% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,718,881 | $25,391,832 | 1.37% |
| COWEN AND COMPANY, LLC | 4,308,359 | $19,129,113 | 1.34% |
| RA Capital Management | 11,609,704 | $51,547,086 | 1.02% |
| RTW INVESTMENTS, LP | 5,818,804 | $25,835,490 | 0.54% |
| Acuitas Investments, LLC | 134,811 | $598,561 | 0.35% |
| Simplify Asset Management Inc. | 570,519 | $2,533,104 | 0.29% |
| Vivo Capital, LLC | 520,000 | $2,308,800 | 0.25% |
| BRANDYWINE MANAGERS, LLC | 26,127 | $116,004 | 0.20% |
| DENALI ADVISORS LLC | 70,600 | $313,464 | 0.11% |